Sickle cell disease trials recruiting in Texas

All Sickle cell disease trials nationally

Cities in Texas

Recruiting trials in Texas

• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: Houston
• A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
  NCT06546670 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 55 Years · Sex: All (male and female) · Texas: Houston
• A Real-World Registry of Chronic Wounds and Ulcers
  NCT02280733 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: The Woodlands
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Texas: Houston
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Texas: Houston
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female) · Texas: Houston
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
  NCT04398628 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Austin, Dallas, Houston, San Antonio
• Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
  NCT06071377 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
  NCT06941389 · Phase: Not specified · Ages: 3 Years to 20 Years · Sex: All (male and female) · Texas: Houston, San Antonio
• Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
  NCT06385886 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
  NCT04657822 · Phase: Phase 4 · Ages: 6 Months to 100 Years · Sex: All (male and female) · Texas: Fort Worth
• Sickle Cell Kidney Biorepository
  NCT07064174 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Dallas
• Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
  NCT07247188 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Texas: Houston
• The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
  NCT06975865 · Phase: Phase 3 · Ages: 10 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
  NCT06260891 · Phase: Phase 2 · Ages: 15 Years to 40 Years · Sex: All (male and female) · Texas: Houston